4//SEC Filing
Aisling Capital IV, LP 4
Accession 0000899243-19-019602
CIK 0001061027other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:15 PM ET
Size
11.9 KB
Accession
0000899243-19-019602
Insider Transaction Report
Form 4
Aisling Capital Partners IV, LP
10% Owner
Transactions
- Purchase
Common Stock
2019-07-15$0.60/sh+2,500,000$1,500,000→ 10,100,000 total(indirect: See footnote)
Aisling Capital Partners IV LLC
10% Owner
Transactions
- Purchase
Common Stock
2019-07-15$0.60/sh+2,500,000$1,500,000→ 10,100,000 total(indirect: See footnote)
ELMS STEVE
10% Owner
Transactions
- Purchase
Common Stock
2019-07-15$0.60/sh+2,500,000$1,500,000→ 10,100,000 total(indirect: See footnote)
Aisling Capital IV, LP
10% Owner
Transactions
- Purchase
Common Stock
2019-07-15$0.60/sh+2,500,000$1,500,000→ 10,100,000 total(indirect: See footnote)
SCHIFF ANDREW N
10% Owner
Transactions
- Purchase
Common Stock
2019-07-15$0.60/sh+2,500,000$1,500,000→ 10,100,000 total(indirect: See footnote)
Footnotes (1)
- [F1]Shares held by Aisling Capital IV, LP ("Aisling"). Aisling Capital Partners IV, LP ("Aisling GP"), is the general partner of Aisling. Aisling Capital Partners IV LLC ("Aisling Partners"), is the general partner of Aisling GP. The individual managing members ("the Aisling Managers"), of Aisling Partners are Andrew Schiff, M.D. and Steve Elms. By virtue of these relationships, Aisling GP, Aisling Partners and the Aisling Managers may be deemed to have voting and investment power over the shares held by Aisling. Each of the reporting persons, other than Aisling, disclaims beneficial ownership of the shares held by Aisling, except to the extent of any pecuniary interest therein, if any.
Documents
Issuer
SUNESIS PHARMACEUTICALS INC
CIK 0001061027
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001652910
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 4:15 PM ET
- Size
- 11.9 KB